MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for April 2014


Physician Views: Life-cycle management strategies in multiple sclerosis – can new versions of Copaxone, Avonex drive market share retention?
Topics: Multiple Sclerosis (MS), Physicians' Offices, Prescription Drugs
Regions: United States
Multiple Sclerosis Partnering 2009-2014
Topics: Multiple Sclerosis (MS), Pharmaceuticals Company Reports
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2013
Topics: Multiple Sclerosis (MS), Drug Discovery
Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2013
Topics: Multiple Sclerosis (MS), Drug Discovery
Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
Topics: Multiple Sclerosis (MS)
Regions: Europe
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules
Topics: Multiple Sclerosis (MS)
Multiple Sclerosis: KOL Insight
Topics: Multiple Sclerosis (MS), Research & Development
Consensus Outlook: Multiple Sclerosis
Topics: Multiple Sclerosis (MS)
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU
Topics: Marketing, Multiple Sclerosis (MS), Physicians' Offices
Regions: United States
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update
Topics: Multiple Sclerosis (MS)
Regions: Global
The Neurotechnology Industry 2013
Topics: Stem Cell, Pain, Alzheimer's Disease, Huntington's, Multiple Sclerosis (MS), Epilepsy, Neurology Devices, Manufacturing, Packaging & Detailing, CNS/Neurology
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it?
Topics: Multiple Sclerosis (MS), Physicians' Offices, CNS/Neurology
Physician Views: Will generic Copaxone have traction in the MS market given emergence of oral therapies?
Topics: Multiple Sclerosis (MS), Physicians' Offices, Generics Drugs
FirstImpact: FDA approval of Aubagio
Topics: Multiple Sclerosis (MS)


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.